Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Nature Medicine, 2024
Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risks

Perry A., Farber-Eger E., Gonzales T. et al.

Olink Explore 3072/384Wider Proteomics StudiesEpidemiologyPlasma

Epilepsy & Behavior, 2024
Assessing the impact of circulating inflammatory cytokines and proteins as drivers and therapeutic targets in epilepsy: A Mendelian randomization study

Wang W., Ma L., Liu M. et al.

Olink Target 96NeurologyPathophysiologyPlasma

International Journal of Molecular Sciences, 2024
Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis

Snir T, Greenman R, Aricha R et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationSerum

New England Journal of Medicine, 2024
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1

Oikonomou V., Smith G., Constantine G. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

European Heart Journal: Acute Cardiovascular Care, 2024
Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit

Patel S., Lopes M., Morrow D. et al.

Olink Target 96CVDPatient StratificationBlood

Analytical Chemistry, 2024
Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates

Beutgen V., Bhagwat A., Steitz A. et al.

Olink Target 96Infectious DiseasesTechnical EvaluationCell Culture Supernatant

JAMA Cardiology, 2024
High Throughput Plasma Proteomics and Risk of Heart Failure and Frailty in Late Life

Ramonfaur D., Buckley L., Arthur V. et al.

Olink Explore 3072/384CVDAgingCross-platform ValidationPlasma

International Journal of Molecular Sciences, 2024
ADAM-17 Activity and Its Relation to ACE2: Implications for Severe COVID-19

Sun J., Edsfeldt A., Svensson J. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Journal of Clinical Medicine, 2024
A Search for New Biological Pathways in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy by Proteomic Research

Menéndez-Valladares P., Acevedo Aguilera R., Núñez-Jurado D. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Nature Aging, 2024
A plasma protein-based risk score to predict hip fractures

Austin T., Nethander M., Fink H. et al.

Olink Explore 3072/384AgingPatient StratificationPlasma

Movement Disorders, 2024
Increased CSF DOPA Decarboxylase Correlates with Lower DaT‐SPECT Binding: Analyses in Biopark and PPMI Cohorts

Khosousi S., Sturchio A., Appleton E. et al.

Olink Target 96NeurologyPatient StratificationCSF

Archives of Dermatological Research, 2024
Genetic analyses unravel the causal association of cytokine levels on lichen simplex chronicus risk: insights from a mendelian randomization study

Yu H., Ou G.

Olink Target 96Dermatological DiseasesPathophysiologyPlasma

PROTEOMICS, 2024
Capillary blood self‐collection for high‐throughput proteomics

El‐Sabawi B., Huang S., Tanriverdi K. et al.

Olink Explore 3072/384Wider Proteomics StudiesTechnical EvaluationCapillary BloodBlood

Science Translational Medicine, 2024
Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes

Chen Z., Satake E., Pezzolesi M. et al.

Olink Target 96NephrologyPathophysiologyPatient StratificationPlasma

International Journal of Obesity, 2024
Metabolic profiling of galectin-1 and galectin-3: a cross-sectional, multi-omics, association study

Fryk E., Rodrigues Silva V., Strindberg L. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

International Urology and Nephrology, 2024
Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study

Yuan D., Yang J., Wu W. et al.

Olink Target 96NephrologyPathophysiologyPlasma

Biomedicines, 2024
Activation of CD14+ Monocytes via the IFN-γ Signaling Pathway Is Associated with Immune-Related Adverse Events in Hepatocellular Carcinoma Patients Receiving PD-1 Inhibition Combination Therapy

Song Y., Pan S., Tian J. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma

BMC Medical Genomics, 2024
Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis

Tan C., Li Y., Wang K. et al.

Olink Target 96OncologyCVDPathophysiologyPlasma

iScience, 2024
Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior

Jansen S., Cutilli A., de Koning C. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Scientific Reports, 2024
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population

Grauen Larsen H., Sun J., Sjögren M. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

3119 publications